Cenk Sokmensuer
Overview
Explore the profile of Cenk Sokmensuer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
90
Citations
406
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Arslan D, Sehlaver S, Guder E, Temena M, Bahcekapili A, Ozdemir U, et al.
Heliyon
. 2025 Mar;
11(4):e42467.
PMID: 40061913
Routine pathology assessment for the tumor grading is currently performed under the microscope by experienced pathologists which might be prone to interpersonal variability and requiring years of experience. Over the...
2.
Kavgaci G, Sahin T, Sokmensuer C, Balaban H, Aksoy S
J Chemother
. 2024 Nov;
:1-6.
PMID: 39610055
Hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer represents the most prevalent subtype of breast cancer. Cyclin-dependent kinase 4/6 (CDK4/6) inhibitors, in combination with endocrine therapy...
3.
Onder S, Kurtulan O, Sokmensuer C, Guler G, Orhan D
Acta Cytol
. 2024 Oct;
68(6):506-515.
PMID: 39401487
Introduction: The objectives of this study were to investigate the variation in the use of indeterminate categories of The Bethesda System for reporting thyroid cytopathology across age groups, particularly focusing...
4.
Eren O, Bagci P, Balci S, Ohike N, Saka B, Sokmensuer C, et al.
Ann Surg Oncol
. 2024 Jul;
31(10):7068-7069.
PMID: 38990222
No abstract available.
5.
Eren O, Bagci P, Balci S, Ohike N, Saka B, Sokmensuer C, et al.
Ann Surg Oncol
. 2024 Jul;
31(10):7001-7011.
PMID: 38955993
Background: Grade 1/2 PanNETs are mostly managed similarly, typically without any adjunct treatment with the belief that their overall metastasis rate is low. In oncology literature, Ki67-index of 10% is...
6.
Yilmaz Y, Zeybel M, Adali G, Cosar A, Sertesen E, Gokcan H, et al.
Hepatol Forum
. 2023 Nov;
4(Suppl 1):1-32.
PMID: 37920782
Nonalcoholic fatty liver disease (NAFLD) is a multisystem disease and is significantly associated with obesity, insulin resistance, type 2 diabetes mellitus, metabolic syndrome, and cardiovascular disease. NAFLD has become the...
7.
In the presence of autoantibodies and iron overload, do not judge a book by its cover: A case report
Yazdali Koylu N, Koylu B, Sokmensuer C, Balaban Y
Hepatol Forum
. 2022 Jul;
2(2):76-79.
PMID: 35783902
The presence of autoantibody positivity with an elevated ferritin level and high transferrin saturation can create a diagnostic dilemma. This report describes the challenging case of 38-year-old male patient who...
8.
Tumer A, Eskicioglu E, Sokmensuer C, Findikoglu T
Turk Patoloji Derg
. 2022 Feb;
39(1):9-14.
PMID: 35102540
Objective: In Turkey, autopsy performers, namely forensic medicine practitioners, are neither pathologists nor have properly received pathology training during residency in contrast to the Anglo-Saxon model of forensic medicine practices,...
9.
Taskin O, Reid M, Bagci P, Balci S, Armutlu A, Demirtas D, et al.
Mod Pathol
. 2021 Dec;
35(6):777-785.
PMID: 34969955
The advancing edge profile is a powerful determinant of tumor behavior in many organs. In this study, a grading system assessing the tumor-host interface was developed and tested in 181...
10.
Gumeler E, Kurtulan O, Arslan S, Karakaya J, Sokmensuer C, Unluturk U, et al.
Jpn J Radiol
. 2021 Nov;
40(5):484-491.
PMID: 34811650
Purpose: To assess polar vessel presence and enhancement 4DCT imaging and their relation with biochemical and histopathological features. Methods: Patients with primary hyperparathyroidism and preoperative 4DCT imaging were screened retrospectively...